Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Gpt2em1flox/Cya
Common Name:
Gpt2-flox
Product ID:
S-CKO-00685
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Gpt2-flox
Strain ID
CKOCMP-108682-Gpt2-B6J-VA
Gene Name
Gpt2
Product ID
S-CKO-00685
Gene Alias
4631422C05Rik; ALT2
Background
C57BL/6JCya
NCBI ID
108682
Modification
Conditional knockout
Chromosome
8
Phenotype
MGI:1915391
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Gpt2em1flox/Cya mice (Catalog S-CKO-00685) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000034136
NCBI RefSeq
NM_173866
Target Region
Exon 4
Size of Effective Region
~1.8 kb
Detailed Document
Click here to download >>
Overview of Gene Research
GPT2, also known as glutamate pyruvate transaminase 2, is a nuclear-encoded mitochondrial enzyme. It catalyzes the reversible transfer of an amino group from glutamate to pyruvate, generating alanine and alpha-ketoglutarate. This reaction is involved in glutamine catabolism and plays a role in replenishing tricarboxylic acid (TCA) cycle intermediates, thus being crucial for cellular metabolism [7].

In glioblastoma, hypoxia-inducible factor (HIF)-2 directly induces GPT2, promoting tumor growth. Genetic or pharmacological inhibition of GPT2 decreases cell growth and migration, and knockout of GPT2 in mice inhibits tumor growth [1]. In triple-negative breast cancer, GPT2 is up-regulated and promotes metastasis. Exosomal GPT2 derived from these cells activates BTRC to enhance metastasis, and GPT2 knockout reduces lung metastasis in mice [2]. In acute myeloid leukemia, IGF2BP2 regulates GPT2 in the glutamine metabolism pathways, and inhibiting IGF2BP2 shows anti-leukemia effects [3]. In the locus coeruleus, GPT2 deficiency in mice causes early neurodegeneration, with loss of tyrosine hydroxylase-positive neurons, abnormal action potentials, and microgliosis and astrogliosis [4]. In breast cancer, GPT2 promotes metastasis through the GABA-GABAA receptor-PKC-CREB signaling pathway, and GPT2 knockout reduces metastasis and prolongs survival in mice [5]. In triple-negative breast cancer, abrogating GPT2 decreases TCA cycle intermediates, impairs mTORC1 activity, and induces autophagy, resulting in decreased tumor growth in xenograft studies [6]. In lung adenocarcinoma, inhibition of GPT2 suppresses tumor growth and increases CD4 and CD8 expression, and shows enhanced antitumor immunity when combined with anti-PD-L1 [8].

In conclusion, GPT2 plays essential roles in various biological processes and disease conditions. Gene knockout mouse models have significantly contributed to understanding its role in cancer, neurodegeneration, and metabolic-related disorders, revealing its potential as a therapeutic target in these disease areas.

References:
1. Zhang, Bo, Chen, Yan, Bao, Lei, Luo, Weibo. 2022. GPT2 Is Induced by Hypoxia-Inducible Factor (HIF)-2 and Promotes Glioblastoma Growth. In Cells, 11, . doi:10.3390/cells11162597. https://pubmed.ncbi.nlm.nih.gov/36010673/
2. Cui, Mingqing, Peng, Jiawei, Zhou, Yuanyuan, Wang, Xixi, Cui, Daxiang. 2023. Exosomal GPT2 derived from triple-negative breast cancer cells promotes metastasis by activating BTRC. In Thoracic cancer, 14, 2018-2025. doi:10.1111/1759-7714.14984. https://pubmed.ncbi.nlm.nih.gov/37287397/
3. Weng, Hengyou, Huang, Feng, Yu, Zhaojin, Huang, Huilin, Chen, Jianjun. 2022. The m6A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia. In Cancer cell, 40, 1566-1582.e10. doi:10.1016/j.ccell.2022.10.004. https://pubmed.ncbi.nlm.nih.gov/36306790/
4. Baytas, Ozan, Kauer, Julie A, Morrow, Eric M. 2022. Loss of mitochondrial enzyme GPT2 causes early neurodegeneration in locus coeruleus. In Neurobiology of disease, 173, 105831. doi:10.1016/j.nbd.2022.105831. https://pubmed.ncbi.nlm.nih.gov/35908744/
5. Li, Na, Xu, Xiang, Liu, Dan, Li, Qun, Mi, Jun. 2023. The delta subunit of the GABAA receptor is necessary for the GPT2-promoted breast cancer metastasis. In Theranostics, 13, 1355-1369. doi:10.7150/thno.80544. https://pubmed.ncbi.nlm.nih.gov/36923530/
6. Mitra, Devina, Vega-Rubin-de-Celis, Silvia, Royla, Nadine, Müller-Decker, Karin, Wiemann, Stefan. 2021. Abrogating GPT2 in triple-negative breast cancer inhibits tumor growth and promotes autophagy. In International journal of cancer, 148, 1993-2009. doi:10.1002/ijc.33456. https://pubmed.ncbi.nlm.nih.gov/33368291/
7. Ouyang, Qing, Kavanaugh, Brian C, Joesch-Cohen, Lena, Liu, Judy S, Morrow, Eric M. 2019. GPT2 mutations in autosomal recessive developmental disability: extending the clinical phenotype and population prevalence estimates. In Human genetics, 138, 1183-1200. doi:10.1007/s00439-019-02057-x. https://pubmed.ncbi.nlm.nih.gov/31471722/
8. Wang, Bolin, Pei, Jinli, Xu, Shengnan, Liu, Jie, Yu, Jinming. 2023. System analysis based on glutamine catabolic-related enzymes identifies GPT2 as a novel immunotherapy target for lung adenocarcinoma. In Computers in biology and medicine, 165, 107415. doi:10.1016/j.compbiomed.2023.107415. https://pubmed.ncbi.nlm.nih.gov/37657356/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest